24% organic sales growth y-o-y Improved gross margin due to price adjustments Opex growth to abate i...
Train Alliance redovisade intäkter på 70,5 MSEK för Q3 2024, främst från projektförsäljningar, med e...
Pharma Equity Group (“PEG” or “the Company”) published its Q3 report for 2024 on the 15th of Novembe...
Redeye has a positive view of Kontigo Care’s directed share issue of approximately SEK10.
Angler Gaming plc (”Angler Gaming” eller ”Bolaget”) levererade en kv3 2024-rapport över vår förvänta...
Redeye states that while Automotive sales came in as expected, Behavioral Research’s unexpectedly we...
Redeye comments on Dala Energi’s Q3 report, which presented no real drama, although reported earning...
Redeye provides an initial take on the Q3 2024 report from Precise Biometrics, which is to be consid...
Redeye saw a sales development that was lower than expected.
Redeye updates on Raketech following weaker-than-expected Q3-results.
Redeye provides an update on Thunderful Group following its Q3 2024 report, which was weaker than ex...
Redeye updates its estimates following Surgical Science’s Q3 2024 report, which beat our expectation...
Føroya Banki has a long track record of adapting to market changes.
Comment re-published: we have corrected a factual error.
- Expect weak Q3, revenue recognition from one project - Raise '24e EBIT by SEK 376m & '25e-'26e by ...
